0001415889-24-017984.txt : 20240624
0001415889-24-017984.hdr.sgml : 20240624
20240624163020
ACCESSION NUMBER: 0001415889-24-017984
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240624
DATE AS OF CHANGE: 20240624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPRINGER TIMOTHY A
CENTRAL INDEX KEY: 0001055624
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38537
FILM NUMBER: 241064748
MAIL ADDRESS:
STREET 1: 36 WOODMAN ROAD
CITY: CHESTNUT HILL
STATE: MA
ZIP: 02467
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tectonic Therapeutic, Inc.
CENTRAL INDEX KEY: 0001681087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 810710585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (339) 666-3320
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 210
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: AVROBIO, Inc.
DATE OF NAME CHANGE: 20180131
FORMER COMPANY:
FORMER CONFORMED NAME: AvroBio, Inc.
DATE OF NAME CHANGE: 20160729
4
1
form4-06242024_080610.xml
X0508
4
2024-06-20
0001681087
Tectonic Therapeutic, Inc.
TECX
0001055624
SPRINGER TIMOTHY A
C/O TECTONIC THERAPEUTIC, INC.
490 ARSENAL WAY, SUITE 210
WATERTOWN
MA
02472
true
false
true
false
0
Common Stock
2024-06-20
4
A
0
2692005
A
2692005
D
Common Stock
2024-06-20
4
A
0
1551116
A
1551116
I
By LLC
Stock Option (Right to Buy)
16.80
2024-06-20
4
A
0
11760
0
A
2034-06-19
Common Stock
11760
11760
D
Received in exchange for 5,037,245 shares of common stock of Tectonic Therapeutic, Inc., a Delaware corporation ("Tectonic"), pursuant to an Agreement and Plan of Merger dated as of January 30, 2024 (the "Merger Agreement") by and among AVROBIO, Inc., a Delaware corporation ("AVROBIO"), Tectonic and Alpine Merger Subsidiary, Inc., a direct, wholly owned subsidiary of AVROBIO (the "Merger Sub"). Under the terms of the Merger Agreement, on June 20, 2024, Merger Sub merged with and into Tectonic (the "Merger"), with Tectonic surviving the Merger as a wholly owned subsidiary of AVROBIO. Upon the closing of the Merger, each share of Tectonic common stock was converted into the right to receive 0.534419990 shares of the Issuer's common stock, after giving effect to a reverse stock split of the Issuer's common stock of 1-for-12. Subsequent to the Merger, the name of the Issuer was changed from AVROBIO, Inc. to Tectonic Therapeutic, Inc.
Received in exchange for 2,902,429 shares of common stock of Tectonic on the same terms and conditions as set forth in footnote (1) herein.
These shares are held by TAS Partners, LLC ("TAS"). The Reporting Person is the sole managing member of TAS and, as such, has sole voting and dispositive power over the shares held by TAS. The Reporting Person disclaims beneficial ownership of the shares held by TAS except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
1/3rd of the shares subject to the option will vest on June 20, 2025, and the balance will vest in equal monthly installments thereafter over the next 24 months, subject in each case to the continuous service of the Reporting Person to the Issuer through the applicable vesting date.
/s/ Daniel Lochner, Attorney-in-Fact
2024-06-24